Diisocyanate asthma: clinical aspects and immunopathogenesis
Tóm tắt
Từ khóa
Tài liệu tham khảo
1996, 96
Baur, 1996, Occupational asthma due to isocyanates, Lung, 174, 23
Bernstein, 1996, Overview of diisocyanate occupational asthma, Toxicology, 111, 181, 10.1016/0300-483X(96)03375-6
Ott, 2000, Respiratory health surveillance in a toluene diisocyanate production unit, 1967–97: clinical observations and lung function analyses, Occup. Environ. Med., 57, 43, 10.1136/oem.57.1.43
van Kampen, 2000, Occupational airway sensitizers: an overview on the respective literature, Am. J. Ind. Med., 38, 164, 10.1002/1097-0274(200008)38:2<164::AID-AJIM7>3.0.CO;2-2
Vandenplas, 1993, Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma, J. Allergy Clin. Immunol., 91, 850, 10.1016/0091-6749(93)90342-D
Clarke, 1981, Isophorone diisocyanate induced respiratory disease (IPDI), Aust. N. Z. J. Med., 11, 290
Kimber, 1996, The role of the skin in the development of chemical respiratory hypersensitivity, Toxicol. Lett., 86, 89, 10.1016/0378-4274(96)03678-8
Karol, 1981, Dermal contact with toluene diisocyanate (TDI) produces respiratory tract sensitivity in guinea pigs, Tox. Appl. Pharmacol., 58, 221, 10.1016/0041-008X(81)90426-9
Petsonk, 2000, Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate, Chest, 118, 1183, 10.1378/chest.118.4.1183
Redlich, 2001, Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers, Am. J. Ind. Med., 39, 587, 10.1002/ajim.1058
England, 2000, Comparison of sampling methods for monomer and polyisocyanates of 1,6-hexamethylene diisocyanate during spray finishing operations, Appl. Occup. Environ. Hyg., 15, 472, 10.1080/104732200301250
Carlton, 2000, Exposures to 1,6-hexamethylene diisocyanate during polyurethane spray painting in the U.S. Air Force, Appl. Occup. Environ. Hyg., 15, 705, 10.1080/10473220050110121
Banks, 1990, Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposures, Chest, 97, 121, 10.1378/chest.97.1.121
Meredith, 2000, Isocyanate exposure and occupational asthma: a case-referent study, Occup. Environ. Med., 57, 830, 10.1136/oem.57.12.830
Maitre, 1996, Urinary hexane diamine as an indicator of occupational exposure to hexamethylene diisocyanate, Int. Arch. Occup. Environ. Health, 69, 65, 10.1007/BF02630741
Lemus, 2001, Development of immunoassays for biomonitoring of hexamethylene diisocyanate exposure, Environ. Health Perspect., 109, 10.1289/ehp.011091103
Redlich, 1999, The immunology and prevention of isocyanate asthma: a model for low molecular weight asthma, Semin. Respir. Crit. Care Med., 20, 591, 10.1055/s-2007-1009478
Friedman-Jimenez, 2000, Clinical evaluation, management, and prevention of work-related asthma, Am. J. Ind. Med., 37, 121, 10.1002/(SICI)1097-0274(200001)37:1<121::AID-AJIM10>3.0.CO;2-S
Redlich, 1996, Immunologic responses to isocyanates in sensitized asthmatic subjects, Chest, 109, 6S, 10.1378/chest.109.3_Supplement.6S
Perrin, 1991, Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents, J. Allergy Clin. Immunol., 87, 630, 10.1016/0091-6749(91)90381-W
Brooks, 1985, Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures, Chest, 88, 376, 10.1378/chest.88.3.376
Leroyer, 1998, Can reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to “sensitisation” to isocyanates?, Thorax, 53, 152, 10.1136/thx.53.2.152
Baur, 1995, Hypersensitivity pneumonitis (extrinsic allergic alveolitis) induced by isocyanates, J. Allergy Clin. Immunol., 95, 1004, 10.1016/S0091-6749(95)70101-X
Vandenplas, 1993, Hypersensitivity pneumonitis-like reaction among workers exposed to diphenylmethane [correction to piphenylmethane] diisocyanate (MDI), Am. Rev. Respir. Dis., 147, 338, 10.1164/ajrccm/147.2.338
Fabbri, 1991, Bronchial hyperresponsiveness, airway inflammation and occupational asthma induced by toluene diisocyanate, Clin. Exp. Allergy, 21, 42, 10.1111/j.1365-2222.1991.tb01705.x
Mapp, 1986, Toluene diisocyanate-induced asthma without airway hyperresponsiveness, Eur. J. Respir. Dis., 68, 89
Bernstein, 1999, Current diagnostic methods for diisocyanate induced occupational asthma, Am. J. Ind. Med., 36, 459, 10.1002/(SICI)1097-0274(199910)36:4<459::AID-AJIM7>3.0.CO;2-W
Chan-Yeung, 1995, Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians, Chest, 108, 1084, 10.1378/chest.108.4.1084
Malo, 1991, Is the clinical history a satisfactory means of diagnosing occupational asthma?, Am. Rev. Respir. Dis., 143, 528, 10.1164/ajrccm/143.3.528
Bright, 1996, Occupational lung disease: 8. The diagnosis of occupational asthma from serial measurements of lung function at and away from work, Thorax, 51, 857, 10.1136/thx.51.8.857
Moscato, 1995, Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of European Academy of Allergy and Clinical Immunology, J. Allergy Clin. Immunol., 96, 295, 10.1016/S0091-6749(95)70048-X
Perrin, 1992, Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge, Eur. Respir. J., 5, 40, 10.1183/09031936.93.05010040
Leroyer, 1998, Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma, Am. J. Respir. Crit. Care Med., 158, 827, 10.1164/ajrccm.158.3.9707093
Kopferschmitt-Kubler, 1998, Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma: a pilot study, Respir. Med., 92, 1093, 10.1016/S0954-6111(98)90400-0
Vandenplas, 1996, Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges, Thorax, 51, 472, 10.1136/thx.51.5.472
Perfetti, 1998, Follow-up of occupational asthma after removal from or diminution of exposure to the responsible agent: relevance of the length of the interval from cessation of exposure, Chest, 114, 398, 10.1378/chest.114.2.398
Cullinan, 1998, Occupational asthma, IgE and IgG, Clin. Exp. Allergy, 28, 668, 10.1046/j.1365-2222.1998.00292.x
Vandenplas, 1993, Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives, Br. J. Ind. Med., 50, 213
Park, 1999, Specific IgG, but not specific IgE, antibodies to toluene diisocyanate–human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results, J. Allergy Clin. Immunol., 104, 847, 10.1016/S0091-6749(99)70297-6
Bernstein, 1997, T cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma, J. Allergy Clin. Immunol., 99, 245, 10.1016/S0091-6749(97)70104-0
Lummus, 1998, Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma, J. Allergy Clin. Immunol., 102, 265, 10.1016/S0091-6749(98)70095-8
Lemiere, 1996, Outcome of specific bronchial responsiveness to occupational agents after removal from exposure, Am. J. Respir. Crit. Care Med., 154, 329, 10.1164/ajrccm.154.2.8756802
Park, 1997, Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure, Clin. Exp. Allergy, 27, 1145, 10.1111/j.1365-2222.1997.tb01151.x
Piirila, 2000, Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma, Am. J. Respir. Crit. Care Med., 162, 516, 10.1164/ajrccm.162.2.9909026
Tarlo, 1997, Outcome determinants for isocyanate induced occupational asthma among compensation claimants, Occup. Environ. Med., 54, 756, 10.1136/oem.54.10.756
Pauluhn, 2000, Respiratory sensitization to diphenyl-methane-4,4′-diisocyanate (MDI) in guinea pigs: impact of particle size on induction and elicitation of response, Toxicol. Sci., 56, 105, 10.1093/toxsci/56.1.105
Monso, 2000, What is the respiratory retention of inhaled hexamethylene diisocyanate?, Eur. Respir. J., 16, 729, 10.1034/j.1399-3003.2000.16d27.x
Kennedy, 1989, Uptake and distribution of 14C during and following inhalation exposure to radioactive toluene diisocyanate, Toxicol. Appl. Pharmacol., 100, 280, 10.1016/0041-008X(89)90314-1
Kennedy, 1993, Autoradiographic analyses of guinea pig airway tissues following inhalation exposure to 14C-labeled methyl isocyanate, Fundam. Appl. Toxicol., 20, 57, 10.1006/faat.1993.1007
Karol, 2001, Cell and molecular biology of chemical asthma, Ann. Allergy Asthma Immunol., 87, 10.1016/S1081-1206(10)62337-X
Liu, 2001, 4-Hydroxy-2-nonenal increases gamma-glutamylcysteine synthetase gene expression in alveolar epithelial cells, Am. J. Respir. Cell. Mol. Biol., 24, 499, 10.1165/ajrcmb.24.4.4307
Peterson, 1998, Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns, Proc. Natl. Acad. Sci. U. S. A., 95, 3071, 10.1073/pnas.95.6.3071
Day, 1997, Formation, solvolysis, and transcarbamoylation reactions of bis(S-glutathionyl) adducts of 2,4- and 2,6-diisocyanatotoluene, Chem. Res. Toxicol., 10, 424, 10.1021/tx960201+
Lantz, 2001, Rapid reduction of intracellular glutathione in human bronchial epithelial cells exposed to occupational levels of toluene diisocyanate, Toxicol. Sci., 60, 348, 10.1093/toxsci/60.2.348
Mapp, 1994, Mechanisms and pathology of occupational asthma [published erratum appears in Eur. Respir. J. 1995 Apr; 8(4):667], Eur. Respir. J., 7, 544, 10.1183/09031936.94.07030544
Lange, 1999, Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene, Chem. Res. Toxicol., 12, 931, 10.1021/tx990045h
Brown, 1982, Inhibition of cholinesterase activity by isocyanates, Toxicol. Appl. Pharmacol., 63, 45, 10.1016/0041-008X(82)90025-4
Jin, 1993, Toluene diisocyanate protein adducts in the bronchoalveolar lavage of guinea pigs exposed to vapors of the chemical, Chem. Res. Toxicol., 6, 906, 10.1021/tx00036a023
Wisnewski, 2000, Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo, Am. J. Respir. Crit. Care Med., 162, 1, 10.1164/ajrccm.162.6.2002086
Karol, 1997, Immunohistochemical detection of toluene diisocyanate (TDI) adducts: I. Pulmonary tissue of guinea pigs following inhalation exposure, Inhalation Toxicol., 9, 63, 10.1080/089583797198277
Redlich, 1997, Airway isocyanate-adducts in asthma induced by exposure to hexamethylene diisocyanate, Scand. J. Work, Environ. Health, 23, 227, 10.5271/sjweh.203
Lange, 1999, Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells., Toxicol Sci., 50, 64, 10.1093/toxsci/50.1.64
Mapp, 1999, Mechanisms of occupational asthma, Ann. Allergy, Asthma, Immunol., 83, 645, 10.1016/S1081-1206(10)62888-8
Bentley, 1994, Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma, J. Invest. Allergol. Clin. Immunol., 4, 222
Bentley, 1992, Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma, J. Allergy Clin. Immunol., 89, 821, 10.1016/0091-6749(92)90437-7
Maestrelli, 1997, Expression of interleukin IL-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI), Clin. Exp. Allergy, 27, 1292, 10.1111/j.1365-2222.1997.tb01174.x
Park, 1998, Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma, J. Korean Med. Sci., 13, 21, 10.3346/jkms.1998.13.1.21
Lemiere, 2000, Characterization of airway inflammation after repeated exposures to occupational agents, J. Allergy Clin. Immunol., 106, 1163, 10.1067/mai.2000.111235
Karol, 1994, Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge, Am. J. Respir. Crit. Care Med., 149, 611, 10.1164/ajrccm.149.3.8118626
Grammer, 1998, Immunologic aspects of isocyanate asthma: IL-1 beta, IL-3, IL-4, sIL2R, and sICAM-1, Allergy Asthma Proc., 19, 301, 10.2500/108854198778557755
Lushniak, 1998, Indirect assessment of 4,4′-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin, Am. J. Ind. Med., 33, 471, 10.1002/(SICI)1097-0274(199805)33:5<471::AID-AJIM6>3.0.CO;2-V
Karol, 1987, The development of an animal model for TDI asthma, Bull. Eur. Physiopathol. Respir., 23, 571
Fabbri, 1987, Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate, Am. Rev. Respir. Dis., 136, 36, 10.1164/ajrccm/136.1.36
Park, 1999, Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma, Clin. Exp. Allergy, 29, 1395, 10.1046/j.1365-2222.1999.00682.x
Finotto, 1991, Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate, Br. J. Ind. Med., 48, 116
Maestrelli, 1994, CD8 T cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate, Scand. J. Work, Environ. Health, 20, 376, 10.5271/sjweh.1383
Bignon, 1994, HLA class II alleles in isocyanate-induced asthma, Am. J. Respir. Crit. Care Med., 149, 71, 10.1164/ajrccm.149.1.8111601
Balboni, 1996, Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57, Eur. Respir. J., 9, 207, 10.1183/09031936.96.09020207
Mapp, 2000, Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma, Clin. Exp. Allergy, 30, 651, 10.1046/j.1365-2222.2000.00807.x
Rihs, 1997, No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma, Am. J. Ind. Med., 32, 522, 10.1002/(SICI)1097-0274(199711)32:5<522::AID-AJIM13>3.0.CO;2-4